1-3 of 3
Sebastian Böttcher
Close
Sort by
Journal Articles

Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia

Clinical Trials & Observations
Stephan Stilgenbauer, Eugen Tausch, Andrew W. Roberts, Matthew S. Davids, Barbara Eichhorst, Michael Hallek, Peter Hillmen, Christof Schneider, Johannes Schetelig, Sebastian Böttcher, Arnon P. Kater, Yanwen Jiang, Michelle Boyer, Relja Popovic, Majd T. Ghanim, Michael Moran, Wendy J. Sinai, Xifeng Wang, Nabanita Mukherjee, Brenda Chyla, William G. Wierda, John F. Seymour
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1992–2004.
https://doi.org/10.1182/bloodadvances.2023011741
Published: 2024
Includes: Supplemental data
Journal Articles

Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia

Clinical Trials & Observations
Robby Engelmann, Nadja Jaekel, Sabrina Jotschke, Beatrice Ludwig-Kraus, Frank Bernhard Kraus, Neha Kumari, Susann Schulze, Michael Hecker, Christina Zahn, Haifa Kathrin Al-Ali, Christian Junghanss, Sebastian Böttcher
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3403–3415.
https://doi.org/10.1182/bloodadvances.2022009054
Published: 2023
Includes: Supplemental data
Journal Articles

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

Sebastian Böttcher, Robby Engelmann, Georgiana Grigore, Paula Fernandez, Joana Caetano, Juan Flores-Montero, Vincent H. J. van der Velden, Michaela Novakova, Jan Philippé, Matthias Ritgen, Leire Burgos, Quentin Lecrevisse, Sandra Lange, Tomas Kalina, Javier Verde Velasco, Rafael Fluxa Rodriguez, Jacques J. M. van Dongen, Carlos E. Pedreira, Alberto Orfao,
Journal: Blood Advances
Blood Adv (2022) 6 (3): 976–992.
https://doi.org/10.1182/bloodadvances.2021005725
Published: 2022
Includes: Supplemental data